Roving Reporter Asks: What Are Recent Breakthroughs Telling Us About the CGT Field’s Maturity? - Scorecard - MDSpire

Roving Reporter Asks: What Are Recent Breakthroughs Telling Us About the CGT Field’s Maturity?

IBTV speaks with industry leaders at ARM’s Meeting on the Med 2026 to explore what recent clinical, regulatory, and commercial milestones reveal about the next phase of cell and gene therapy

  • June 25, 2026

  • 2 min

Share

Clinical Scorecard: Roving Reporter Asks: What Are Recent Breakthroughs Telling Us About the CGT Field’s Maturity?

At a Glance

CategoryDetail
ConditionCell and Gene Therapy (CGT)
Key MechanismsInnovative regulatory pathways and reimbursement models
Target PopulationPatients with sensory disorders, rare diseases, and other areas of high unmet need
Care SettingLife sciences industry and clinical research

Key Highlights

  • Regeneron's approval for inherited deafness marks a milestone for CGT.
  • Gene therapies are extending beyond oncology into broader disease areas.
  • Industry leaders discuss commercialization challenges and long-term sustainability.
  • Emerging approaches such as in vivo therapies are being explored.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients with inherited conditions and high unmet medical needs

          Clinical value of gene therapies is becoming clearer across various diseases.

          Clinical Best Practices

          • Focus on innovative regulatory pathways for CGT.
          • Develop new reimbursement models to support therapy access.
          • Address commercialization challenges to enhance patient reach.

          Related Resources & Content

            Original Source(s)

            Roving Reporter Asks: What Are Recent Breakthroughs Telling Us About the CGT Field’s Maturity?

            • June 25, 2026

            Related Content

            Radiological risk factors for T2-T3 glottic carcinoma treated with (chemo)radiotherapy—a multicenter analysis

            Validation of a portable video head impulse test using an iPod touch and an oral stabilization three-dimensional (3D) - printed mount: a method-comparison study

            Toward personalized medicine for mal de débarquement syndrome